Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Canf exchanges : Amex save search
Can-Fite: Scientific Article Published by KOL Presents Namodenoson as a Promising Drug Candidate to Treat Advanced Liver Cancer and MASH
Published: 2024-04-15 (Crawled : 13:00) - biospace.com/
CANF | $1.99 1.02% -0.5% 7.8K
|
Health Technology
|
| O: 4.76%
H: 0.45%
C: -5.91%
drug candidate liver cancer treat namodenoson advanced
Can-Fite: Submits FDA with an IND Application to Conduct Phase IIb Clinical Trial of Namodenoson in MASH Patients
Published: 2024-04-03 (Crawled : 12:00) - biospace.com/
CANF | $1.99 1.02% -0.5% 7.8K
|
Health Technology
|
| O: 2.45%
H: 0.87%
C: -0.43%
fda namodenoson application trial
Namodenoson Treatment for Pancreatic and Liver Cancer: Data will be Discussed in Out-licensing and Distribution Partnering Meetings at Bio Europe Conference
Published: 2024-03-11 (Crawled : 12:30) - biospace.com/
CANF | $1.99 1.02% -0.5% 7.8K
|
Health Technology
|
| O: -0.45%
H: 2.27%
C: 2.27%
europe liver conference distribution pancreatic treatment namodenoson
Can-Fite Broadens its Strong Intellectual Property (IP) for NASH: Received Patent Allowance in Canada
Published: 2024-02-28 (Crawled : 12:30) - biospace.com/
CANF | $1.99 1.02% -0.5% 7.8K
|
Health Technology
|
| O: -1.9%
H: 4.37%
C: 0.98%
patent canada
Can-Fite Expands the Out-Licensing Deal with Ewopharma to Include the Pancreatic Cancer Indication
Published: 2024-01-30 (Crawled : 13:30) - biospace.com/
CANF | $1.99 1.02% -0.5% 7.8K
|
Health Technology
|
| O: 5.24%
H: 2.71%
C: -4.75%
cancer pancreatic deal
Can-Fite Received FDA Positive Response to Psoriasis Pediatric Plan
Published: 2023-12-18 (Crawled : 13:30) - biospace.com/
CANF | $1.99 1.02% -0.5% 7.8K
|
Health Technology
|
| O: 4.69%
H: 3.77%
C: -2.83%
fda psoriasis positive response
Can-Fite’s Namodenoson for the Treatment of Pancreatic Cancer Patients: Progress in Clinical Development
Published: 2023-12-04 (Crawled : 13:30) - biospace.com/
CANF | $1.99 1.02% -0.5% 7.8K
|
Health Technology
|
| O: 0.0%
H: 1.23%
C: -4.92%
cancer pancreatic treatment namodenoson
Can-Fite Announces Exercise of Warrants for Approximately $3.0 Million in Gross Proceeds
Published: 2023-11-21 (Crawled : 19:00) - globenewswire.com
CANF | $1.99 1.02% -0.5% 7.8K
|
Health Technology
|
| O: 0.93%
H: 0.0%
C: -2.39%
Can-Fite Issues Business Update: All Clinical Programs and Business Development Activities Remain Solidly on Track
Published: 2023-11-01 (Crawled : 12:00) - biospace.com/
CANF | $1.99 1.02% -0.5% 7.8K
|
Health Technology
|
| O: 4.93%
H: 2.81%
C: -0.0%
business
Can-Fite Novel Approach for the Treatment of Pancreatic Carcinoma with Namodenoson Receives Appreciation of the American Association of Cancer Research (AACR)
Published: 2023-09-27 (Crawled : 13:00) - biospace.com/
CANF | $1.99 1.02% -0.5% 7.8K
|
Health Technology
|
| O: 5.79%
H: 1.82%
C: -8.76%
association cancer pancreatic treatment namodenoson research
Can-Fite to Share with Investors Latest Oncology and Rare Genetic Disease Developments at the H.C. Wainwright 25th Annual Conference
Published: 2023-09-07 (Crawled : 15:30) - biospace.com/
CANF | $1.99 1.02% -0.5% 7.8K
|
Health Technology
|
| O: 0.0%
H: 0.18%
C: -0.18%
rare conference disease genetic
Can-Fite Submitted to FDA a Pediatric Plan to Allow Registration of Piclidenoson for the Treatment of Adolescents with Psoriasis
Published: 2023-08-18 (Crawled : 14:00) - biospace.com/
CANF | $1.99 1.02% -0.5% 7.8K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
fda piclidenoson psoriasis treatment
Can-Fite: Granted Breakthrough Abstract Award for Namodenoson in Treatment of Advanced Liver Cancer by ASCO Conquer Cancer Foundation
Published: 2023-07-17 (Crawled : 13:00) - biospace.com/
CANF | $1.99 1.02% -0.5% 7.8K
|
Health Technology
|
| O: 1.97%
H: 2.43%
C: 0.32%
award liver granted asco cancer treatment namodenoson
Can-Fite to Present at the Emerging Growth Conference on July 13, 2023
Published: 2023-07-07 (Crawled : 15:00) - biospace.com/
CANF | $1.99 1.02% -0.5% 7.8K
|
Health Technology
|
| O: -1.56%
H: 5.94%
C: 3.14%
conference growth
Can-Fite Receives U.S. FDA’s Go Ahead for Piclidenoson Psoriasis Registration Plan
Published: 2023-06-29 (Crawled : 12:20) - biospace.com/
CANF | $1.99 1.02% -0.5% 7.8K
|
Health Technology
|
| O: 9.93%
H: 0.0%
C: -9.04%
piclidenoson psoriasis
Can-Fite to Participate in Out-licensing and Distribution Partnering Meetings at Bio International Convention in Boston
Published: 2023-06-02 (Crawled : 12:00) - biospace.com/
CANF | $1.99 1.02% -0.5% 7.8K
|
Health Technology
|
| O: 1.12%
H: 9.59%
C: 2.95%
distribution international
Can-Fite Reports First Quarter 2023 Financial Results & Provides Clinical Update
Published: 2023-06-01 (Crawled : 12:00) - biospace.com/
CANF | $1.99 1.02% -0.5% 7.8K
|
Health Technology
|
| O: -4.26%
H: 8.5%
C: 8.5%
update financial results
Can-Fite: Namodenoson’s Inhibition of Pancreatic Carcinoma Receives Recognition from the American Society of Clinical Oncology (ASCO)
Published: 2023-05-30 (Crawled : 12:20) - biospace.com/
CANF | $1.99 1.02% -0.5% 7.8K
|
Health Technology
|
| O: 7.14%
H: 3.33%
C: 2.71%
pancreatic
Can-Fite: Presenting Namodenoson’s New Pancreatic Cancer Indication to Potential Partners at BioEquity Europe 2023
Published: 2023-05-15 (Crawled : 12:00) - biospace.com/
CANF | $1.99 1.02% -0.5% 7.8K
|
Health Technology
|
| O: 0.47%
H: 0.0%
C: -1.4%
europe cancer pancreatic potential
Inhibition of Pancreatic Cancer by Namodenoson: Molecular Mechanism of Action Discovered by Can-Fite Scientists
Published: 2023-05-02 (Crawled : 12:00) - biospace.com/
CANF | $1.99 1.02% -0.5% 7.8K
|
Health Technology
|
| O: 13.14%
H: 2.02%
C: 1.01%
cancer pancreatic molecular
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.